BIOMAT Database Logo BIOMAT Database Logo

Neutral and acidic human tracheobronchial mucin. Isolation and characterization of core protein. 1990

S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Department of Clinical Investigation, William Beaumont Army Medical Center, El Paso, Texas.

Human bronchial mucin from a patient suffering from chronic bronchitis was solubilized in aqueous solution containing sodium azide and protease inhibitors and purified by Sepharose 4B and 2B column chromatography. The mucin was further purified by cesium bromide density gradient centrifugation. Sodium dodecyl sulfate-polyacrylamide gel (7.5%) electrophoresis of this material showed high-molecular-weight mucin component(s) at the top of the gel. Chemical analysis of this preparation indicated a typical mucin profile of amino acids and carbohydrates. Ion-exchange chromatography resulted in resolution of the purified mucin into neutral and acidic fractions. Comparison of the chemical composition of these two fractions showed higher mole percentage of threonine, serine, sialic acid, and sulfate in the acidic fraction. Chemical deglycosylation of the purified mucin preparation with trifluoromethane sulfonic acid was carried out at 20 degrees C for 3 1/2 h. Sialic acid, fucose, galactose, and N-acetylglucosamine were completely removed, whereas traces of N-acetylgalactosamine were still detected. High-pressure liquid chromatography of the deglycosylated products from native, neutral, and acidic mucin preparations resulted in a principal peptide, P1, with identical amino acid composition. Cyanogen bromide (CNBr) treatment of the peptide P1 from neutral and acidic mucins and subsequent fractionation of the fragments by high-pressure liquid chromatography resulted in similar peptide profiles. The P1 peptide fraction was further subjected to high-pressure liquid chromatography in a second solvent system, which resulted in two peaks, P1a and P1b. Gel filtration of both peptides in 6 M guanidine hydrochloride indicated a single peak with molecular weight of approximately 97 kDa. The amino acid profile of the two peptides was dominated by high levels of threonine, serine, and proline, which combined accounted for nearly 39% of the total residues, and in most respects, the profile resembled that of native mucin. End-group analysis of the peptide P1a indicated a blocked N-terminus, whereas serine was found to be the N-terminal amino acid in the peptide P1b. Rabbit antibodies prepared against the peptide P1 from native tracheal mucin reacted strongly with neutral and acidic mucin as well as the mucin from human colon. Both neutral and acidic human tracheal mucins were immunologically reactive with mouse monoclonal antibody HMPFG-2, which was prepared against human mammary mucin. However, the response of this antibody to human colonic mucin was rather weak.

UI MeSH Term Description Entries
D009077 Mucins High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. Mucin
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002241 Carbohydrates A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrate
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations

Related Publications

S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Neutral and acidic species of human intestinal mucin. Evidence for different core peptides.
July 1985, The Journal of biological chemistry,
S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Deglycosylation of neutral and acidic human colonic mucin.
February 1990, Inflammation,
S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Isolation and characterization of tracheobronchial mucin from a laryngectomee.
December 1984, Carbohydrate research,
S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Characterization of human tracheobronchial mucin glycoproteins.
January 1989, Methods in enzymology,
S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Isolation and characterization of peptides from the protein core of bovine gallbladder mucin.
June 1990, Gastroenterology,
S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Protein components of human tracheobronchial mucin: partial characterization of a closely associated 65-kilodalton protein.
October 1988, Biochemistry,
S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Structural characterization of neutral oligosaccharides of human midcycle cervical mucin.
March 1982, The Journal of biological chemistry,
S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Purification and characterization of monkey (Macaca nemestrina) tracheobronchial mucin.
April 1993, Archives of biochemistry and biophysics,
S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Isolation, chemical composition, and properties of the major mucin component of normal human tracheobronchial secretions.
August 1980, Biochemical medicine,
S N Bhattacharyya, and B C Veit, and B Manna, and J I Enriquez, and M P Walker, and A M Khorrami, and B Kaufman
Structural characterization of neutral oligosaccharides of human H+Leb+ gastric mucin.
March 1984, The Journal of biological chemistry,
Copied contents to your clipboard!